We are live on ! Find out more
AB

Amalgamated Bank Portfolio holdings

AUM $14.5B
1-Year Est. Return 44.3%
This Fund
S&P 500
This Quarter Est. Return
-3%
1 Year Est. Return
+44.3%
3 Year Est. Return
+131.76%
5 Year Est. Return
+175.18%
10 Year Est. Return
+715.35%
AUM
$12.9B
AUM Growth
-$678M
Cap. Flow
+$6.37M
Cap. Flow %
0.05%
Top 10 Hldgs %
23.8%
Holding
3,083
New
921
Increased
335
Reduced
1,799
Closed
24

Top Buys

Rank Stock Value
1
ACN icon
Accenture
ACN
+$60.7M
2
MDT icon
Medtronic
MDT
+$35.8M
3
AAPL icon
Apple
AAPL
+$30.8M
4
MSFT icon
Microsoft
MSFT
+$28.5M
5
LIN icon
Linde
LIN
+$24.3M

Sector Composition

Rank Sector Weight
1 Technology 24.64%
2 Financials 13.28%
3 Healthcare 13.15%
4 Consumer Discretionary 12.03%
5 Industrials 9.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRLD icon
2926
Prelude Therapeutics
PRLD
$366M
$12K ﹤0.01%
+1,764
New +$16.1K
STIM icon
2927
Neuronetics
STIM
$138M
$12K ﹤0.01%
+4,043
New +$13.7K
TNXP icon
2928
Tonix Pharmaceuticals
TNXP
$160M
0
UAVS icon
2929
AgEagle Aerial Systems
UAVS
$40.9M
$12K ﹤0.01%
10
-1
-9% -$1.18K
VHC icon
2930
VirnetX Holding Corp
VHC
$54.4M
$12K ﹤0.01%
+382
New +$15.6K
NEXI
2931
DELISTED
NexImmune, Inc. Common Stock
NEXI
$12K ﹤0.01%
+110
New +$8.08K
TRVN
2932
DELISTED
Trevena, Inc.
TRVN
$12K ﹤0.01%
36
-2
-5% -$631
AWH
2933
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$12K ﹤0.01%
789
-67
-8% -$1.16K
RAIN
2934
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$12K ﹤0.01%
+2,368
New +$19K
EBET
2935
DELISTED
EBET, INC. Common Stock
EBET
$12K ﹤0.01%
+60
New +$18.7K
LOTZ
2936
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
$12K ﹤0.01%
+8,655
New +$16.3K
CRDF icon
2937
Cardiff Oncology
CRDF
$66.5M
$11K ﹤0.01%
+4,585
New +$16.2K
FLNT
2938
Fluent
FLNT
$102M
$11K ﹤0.01%
+870
New +$8.88K
FTHM icon
2939
Fathom Holdings
FTHM
$26.4M
$11K ﹤0.01%
+1,003
New +$13.9K
IBIO icon
2940
iBio
IBIO
$69.5M
$11K ﹤0.01%
52
-4
-7% -$837
LSEA
2941
DELISTED
Landsea Homes
LSEA
$11K ﹤0.01%
+1,293
New +$9.63K
LITS
2942
Lite Strategy Inc
LITS
$32.8M
$11K ﹤0.01%
885
-72
-8% -$2.83K
MIRM icon
2943
Mirum Pharmaceuticals
MIRM
$6.46B
$11K ﹤0.01%
+516
New +$10.5K
PLSE icon
2944
Pulse Biosciences
PLSE
$2.43B
$11K ﹤0.01%
+2,273
New +$18.6K
SMMT icon
2945
Summit Therapeutics
SMMT
$10.4B
$11K ﹤0.01%
+4,291
New +$10.8K
SYRE icon
2946
Spyre Therapeutics
SYRE
$8.54B
$11K ﹤0.01%
+195
New +$16.4K
VEL icon
2947
Velocity Financial
VEL
$689M
$11K ﹤0.01%
+1,032
New +$12.7K
WLFC icon
2948
Willis Lease Finance
WLFC
$1.7B
$11K ﹤0.01%
+1,068
New +$12.4K
XGN icon
2949
Exagen
XGN
$109M
$11K ﹤0.01%
+1,395
New +$12K
VINC
2950
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$11K ﹤0.01%
+134
New +$16.6K

Similar funds

Amalgamated Bank's Q1 2022 Portfolio in Review

As of Q1 2022, Amalgamated Bank held 3,083 positions worth $12.9B, down 5% from $13.5B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Amalgamated Bank's Q1 2022 filing shows 921 new, 335 increased, 1,799 reduced and 24 closed positions. Its largest new stake was Accenture: 180,111 shares worth $60.7M. The largest sale was iShares Core S&P 500 ETF, an estimated $21M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • Amalgamated Bank's largest Q1 2022 buy was Accenture: 180,111 shares worth $60.7M.
  • Amalgamated Bank added most to Apple in Q1 2022, an estimated $30.8M increase.
  • Amalgamated Bank's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $21M.
  • Amalgamated Bank fully exited iShares Russell 3000 ETF in Q1 2022, selling an estimated $15.3M.
  • Amalgamated Bank's ten largest holdings make up 24% of its $12.9B portfolio in Q1 2022.
  • Amalgamated Bank opened 921 new positions and closed 24 in Q1 2022.
  • Amalgamated Bank's portfolio value fell 5% quarter-over-quarter to $12.9B.

Based on Amalgamated Bank's 13F filing for Q1 2022, filed 30 Jun 2022.